Vanguard Capital Management
WGS icon

Vanguard Capital Management’s GeneDx Holdings WGS Stock Holding History

Vanguard Capital Management’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.3M Buy
879,003
+20,420
+2% +$1.16M ﹤0.01% 1830
2026
Q1 		$55.1M Buy
+858,583
New +$78.3M ﹤0.01% 1809

Other funds holding WGS

CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Capital Management's WGS Position: Q2 2026 in Review

Vanguard Capital Management increased its GeneDx Holdings (WGS) stake by 2.4% in Q2 2026, buying an estimated $1.16M and bringing the position to 879,003 shares worth $60.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1830.

Vanguard Capital Management first reported a position in WGS in Q1 2026 and has held it in 2 quarters since. 222 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Vanguard Capital Management held 879,003 shares of GeneDx Holdings worth $60.3M as of Q2 2026.
  • Vanguard Capital Management bought 20,420 GeneDx Holdings shares in Q2 2026, an estimated $1.16M.
  • GeneDx Holdings made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #1830 holding.
  • Vanguard Capital Management first reported a position in GeneDx Holdings in Q1 2026 and has held it in 2 quarters since.
  • 222 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.